Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

EHA 2025
Published Online: Jul 30th 2025

“These reports not only showcase groundbreaking advancements in both malignant and non-malignant hematology but also embody our commitment to enhancing the understanding and accessibility of pivotal research. We believe these insights will inspire innovation and collaboration among clinicians, researchers, and stakeholders alike”

Prof Konstanze Döhner, President of EHA, Ulm University, Germany

EHA Perspectives on Malignant Hematology – Congress Report
EHA Perspectives on Malignant Hematology – Slide Deck
EHA Perspectives on Non-malignant Hematology – Congress Report
EHA Perspectives on Non-malignant Hematology – Slide Deck

The European Hematology Association (EHA) has released its official EHA Perspectives in Hematology reports from the 2025 Annual Congress in Milan, now available in two separate editions covering malignant and non-malignant hematology. Following strong interest in the 2024 pilot report, this expanded format offers deeper insights into scientific and clinical advances across the field.

The EHA2025 congress in Milan featured over 575 scientific and abstract presentations, attracting 17,780 delegates from 140 countries. Developed in collaboration with leading experts, the reports provide concise summaries of key findings for clinicians, researchers and stakeholders.

The malignant hematology report covers topics such as myeloid and lymphoid malignancies, immunotherapy, AI, precision medicine, and quality of life. The non-malignant report highlights advances in bone marrow failure, sickle cell disease, platelet disorders, iron metabolism and bleeding/thrombotic conditions.

Both reports are available as user-friendly slide decks designed to support clinical practice and inspire future research.

About EHA

The European Hematology Association (EHA) is a membership organization serving a community of 10,000+ medical professionals, researchers, and scientists with an active interest in hematology. EHA is the largest Europe-based organization connecting hematologists worldwide and supports career development and research, harmonizes hematology education, and advocates for hematologists and hematology. “Towards prevention, cure, and quality of life for all patients with blood disorders”.

Cite: EHA Perspectives in Hematology: EHA2025 Congress Reports now available. July 30th, 2025

SIGN UP to touchHAEMATOLOGY!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup